420 related articles for article (PubMed ID: 36614146)
1. TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine.
Spekker E; Körtési T; Vécsei L
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614146
[TBL] [Abstract][Full Text] [Related]
2. Targeting TRP channels for novel migraine therapeutics.
Dussor G; Yan J; Xie JY; Ossipov MH; Dodick DW; Porreca F
ACS Chem Neurosci; 2014 Nov; 5(11):1085-96. PubMed ID: 25138211
[TBL] [Abstract][Full Text] [Related]
3. Implications of Transient Receptor Potential Cation Channels in Migraine Pathophysiology.
Shibata M; Tang C
Neurosci Bull; 2021 Jan; 37(1):103-116. PubMed ID: 32870468
[TBL] [Abstract][Full Text] [Related]
4. The role of TRP ion channels in migraine and headache.
Iannone LF; De Logu F; Geppetti P; De Cesaris F
Neurosci Lett; 2022 Jan; 768():136380. PubMed ID: 34861342
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Connections of the TRPA1 Ion Channel in Pain Transmission and Neurogenic Inflammation - a Therapeutic Perspective in Migraine?
Fila M; Pawlowska E; Szczepanska J; Blasiak J
Mol Neurobiol; 2023 Oct; 60(10):5578-5591. PubMed ID: 37326902
[TBL] [Abstract][Full Text] [Related]
6. TRPA1 and other TRP channels in migraine.
Benemei S; De Cesaris F; Fusi C; Rossi E; Lupi C; Geppetti P
J Headache Pain; 2013 Aug; 14(1):71. PubMed ID: 23941062
[TBL] [Abstract][Full Text] [Related]
7. The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system.
Citak A; Kilinc E; Torun IE; Ankarali S; Dagistan Y; Yoldas H
Cephalalgia; 2022 Nov; 42(13):1375-1386. PubMed ID: 35861239
[TBL] [Abstract][Full Text] [Related]
8. Expression of the transient receptor potential channels TRPV1, TRPA1 and TRPM8 in mouse trigeminal primary afferent neurons innervating the dura.
Huang D; Li S; Dhaka A; Story GM; Cao YQ
Mol Pain; 2012 Sep; 8():66. PubMed ID: 22971321
[TBL] [Abstract][Full Text] [Related]
9. The TRPA1 channel in migraine mechanism and treatment.
Benemei S; Fusi C; Trevisan G; Geppetti P
Br J Pharmacol; 2014 May; 171(10):2552-67. PubMed ID: 24206166
[TBL] [Abstract][Full Text] [Related]
10. TRP Channels and Migraine: Recent Developments and New Therapeutic Opportunities.
Benemei S; Dussor G
Pharmaceuticals (Basel); 2019 Apr; 12(2):. PubMed ID: 30970581
[TBL] [Abstract][Full Text] [Related]
11. The TRPA1 channel in inflammatory and neuropathic pain and migraine.
Nassini R; Materazzi S; Benemei S; Geppetti P
Rev Physiol Biochem Pharmacol; 2014; 167():1-43. PubMed ID: 24668446
[TBL] [Abstract][Full Text] [Related]
12. TRP Channels in the Focus of Trigeminal Nociceptor Sensitization Contributing to Primary Headaches.
Dux M; Rosta J; Messlinger K
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31948011
[TBL] [Abstract][Full Text] [Related]
13. Functional interactions between transient receptor potential M8 and transient receptor potential V1 in the trigeminal system: Relevance to migraine pathophysiology.
Kayama Y; Shibata M; Takizawa T; Ibata K; Shimizu T; Ebine T; Toriumi H; Yuzaki M; Suzuki N
Cephalalgia; 2018 Apr; 38(5):833-845. PubMed ID: 28554243
[TBL] [Abstract][Full Text] [Related]
14. The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model.
Demartini C; Tassorelli C; Zanaboni AM; Tonsi G; Francesconi O; Nativi C; Greco R
J Headache Pain; 2017 Sep; 18(1):94. PubMed ID: 28884307
[TBL] [Abstract][Full Text] [Related]
15. Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine.
Kopruszinski CM; Thornton P; Arnold J; Newton P; Lowne D; Navratilova E; Swiokla J; Dodick DW; Dobson C; Gurrell I; Chessell IP; Porreca F
Cephalalgia; 2020 Dec; 40(14):1535-1550. PubMed ID: 33131305
[TBL] [Abstract][Full Text] [Related]
16. Xenobiotic Exposure and Migraine-Associated Signaling: A Multimethod Experimental Study Exploring Cellular Assays in Combination with
Rasmussen RH; Christensen SL; Calloe K; Nielsen BS; Rehfeld A; Taylor-Clark TE; Haanes KA; Taboureau O; Audouze K; Klaerke DA; Olesen J; Kristensen DM
Environ Health Perspect; 2023 Nov; 131(11):117003. PubMed ID: 37909725
[TBL] [Abstract][Full Text] [Related]
17. Transient receptor potential ion channel function in sensory transduction and cellular signaling cascades underlying visceral hypersensitivity.
Balemans D; Boeckxstaens GE; Talavera K; Wouters MM
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G635-G648. PubMed ID: 28385695
[TBL] [Abstract][Full Text] [Related]
18. Neurotrophins and Migraine.
Martins LB; Teixeira AL; Domingues RB
Vitam Horm; 2017; 104():459-473. PubMed ID: 28215304
[TBL] [Abstract][Full Text] [Related]
19. [Pathophysiology of migraine chronification].
Shibata M
Rinsho Shinkeigaku; 2013; 23(11):1220-2. PubMed ID: 24291936
[TBL] [Abstract][Full Text] [Related]
20. TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis.
Schwartz ES; La JH; Scheff NN; Davis BM; Albers KM; Gebhart GF
J Neurosci; 2013 Mar; 33(13):5603-11. PubMed ID: 23536075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
